Head and Neck Surgical Oncology

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

Comprehensive genomic characterization of head and neck squamous cell carcinomas

Head and neck squamous cell carcinoma

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

Classification of Surgical Complications

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

Toxicity and response criteria of the Eastern Cooperative Oncology Group

The Clavien-Dindo Classification of Surgical Complications

Cancer: Principles and Practice of Oncology.

Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Oncology Meets Immunology: The Cancer-Immunity Cycle

A Surgical Safety Checklist to Reduce Morbidity and Mortality in a Global Population

Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)